PUMA BIOTECHNOLOGY INC
$9.39
Market Cap
$484.71M
Shares Outstanding
51.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 21, 2012
Round Lot
100
Locale
US
Day Open
$9.26
Day High
$9.40
Day Low
$9.16
Volume
188.8K
VWAP
$9.29
Prev Close
$9.25
Transactions
--
Acc. Volume
--
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
PUMA BIOTECHNOLOGY INC (PBYI) closed the 2026-09-16 session at $9.39, up 1.51% versus the previous close (+0.14). The stock opened at $9.26 and traded between $9.16 and $9.40 during that session. Session trading volume was 189K shares. The volume-weighted average price (VWAP) is $9.29.
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
PUMA BIOTECHNOLOGY INC has a market capitalization of $484.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. PBYI is listed on the XNAS exchange. The company employs approximately 179 people. PUMA BIOTECHNOLOGY INC is headquartered in LOS ANGELES, CA. The recorded listing date is 2012-03-21.
On this page you can find market PBYI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.